Rezubio Pharmaceuticals has secured $20 million in Series A financing, led by Lapam Capital, to advance its therapeutics platform targeting obesity and diabetes.
Amount Raised
$20 Million
Round Type
Series A
ZhuhaiBiotechnologyHealth CareTherapeuticsInvestors
Description
Rezubio, a China-based biotechnology company, announced the closing of a $20 million Series A financing. The funds will enhance the company’s lead program into Phase 2 clinical development for obesity and diabetes. The financing was led by Lapam Capital, with participation from Frees Fund and Riverhead Capital. This funding marks a significant milestone for Rezubio as it works towards innovative drug design using its MADD platform.
Quick answer
Rezubio Pharmaceuticals raised $20 Million in a Series A round, dated December 19, 2025. Investors: Frees Fund, Riverhead Capital and Lapam Capital. Rezubio Pharmaceuticals is based in Zhuhai, Guangdong, China.
- How much did Rezubio Pharmaceuticals raise?
- Rezubio Pharmaceuticals raised $20 Million in a Series A round on December 19, 2025.
- Who invested in Rezubio Pharmaceuticals?
- Frees Fund, Riverhead Capital and Lapam Capital are named as investors in this round.
- What does Rezubio Pharmaceuticals do?
- Rezubio is a biotechnology company based in China, founded by former Merck scientists.
- Where is Rezubio Pharmaceuticals based and how big is it?
- Rezubio Pharmaceuticals is based in Zhuhai, Guangdong, China.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Rezubio Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- CytoDyn raised $19M on January 30, 2026.
- PranaX raised $17M (Series A) on January 29, 2026.
- Tenpoint Therapeutics raised $235M (Series B) on January 29, 2026.
- Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
- Altido Bio raised $13M (Seed) on January 28, 2026.
- CraniUS raised $20M (Series B) on January 28, 2026.
Who to call at Rezubio Pharmaceuticals, and when
A new round usually means Rezubio Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rezubio Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rezubio Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rezubio Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rezubio Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansRezubio Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.